APA

Hyman D. M., Snyder A. E., Carvajal R. D., Gerecitano J. F., Voss M. H., Ho A. L., Konner J., Winkelmann J. L., Stasi M. A., Monson K. R., Iasonos A., Spriggs D. R., Bialer P., Lacouture M. E., Teitcher J. B., Katabi N. & Fury M. G. (20150526). Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors. : Cancer chemotherapy and pharmacology.

Chicago

Hyman David M, Snyder Alexandra E, Carvajal Richard D, Gerecitano John F, Voss Martin H, Ho Alan L, Konner Jason, Winkelmann Jennifer L, Stasi Megan A, Monson Kelsey R, Iasonos Alexia, Spriggs David R, Bialer Philip, Lacouture Mario E, Teitcher Jerrold B, Katabi Nora and Fury Matthew G. 20150526. Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors. : Cancer chemotherapy and pharmacology.

Harvard

Hyman D. M., Snyder A. E., Carvajal R. D., Gerecitano J. F., Voss M. H., Ho A. L., Konner J., Winkelmann J. L., Stasi M. A., Monson K. R., Iasonos A., Spriggs D. R., Bialer P., Lacouture M. E., Teitcher J. B., Katabi N. and Fury M. G. (20150526). Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors. : Cancer chemotherapy and pharmacology.

MLA

Hyman David M, Snyder Alexandra E, Carvajal Richard D, Gerecitano John F, Voss Martin H, Ho Alan L, Konner Jason, Winkelmann Jennifer L, Stasi Megan A, Monson Kelsey R, Iasonos Alexia, Spriggs David R, Bialer Philip, Lacouture Mario E, Teitcher Jerrold B, Katabi Nora and Fury Matthew G. Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors. : Cancer chemotherapy and pharmacology. 20150526.